What Is SLU-PP-332?
SLU-PP-332 is a research compound studied for its ability to bind estrogen related receptors (ERRα, ERRβ, and ERRγ). These receptors are highly expressed in metabolically active tissues like skeletal muscle, heart, and liver, which is why the downstream discussion around SLU tends to span fat oxidation, endurance signaling, and broader metabolic health endpoints. In mechanistic terms, it is often framed as a mitochondrial and oxidative metabolism modulator rather than a simple stimulant style fat burner.
Mechanisms of Action
ERR binding and transcriptional activation that shifts cellular programs toward higher oxidative metabolism and energy production signaling.
Mitochondrial biogenesis signaling that may increase mitochondrial content and capacity, expanding the cellular machinery available for fat oxidation.
Skeletal muscle specific fat oxidation support, with reports of increased endurance capacity and greater lipid utilization within muscle fibers in model settings.
AMPK linked energy stress signaling and autophagy related pathways that are conceptually similar to caloric restriction style signals in some mechanistic discussions.
Cardiometabolic support rationale based on ERR pathway relevance in heart function and protection signaling, which is why ERR activation is discussed beyond cosmetic outcomes.
Benefits
Improved fat oxidation signaling and oxidative metabolism markers in model contexts.
Endurance and aerobic adaptation like effects in research discussions, often described as exercise mimic style signaling rather than acute thermogenesis.
Metabolic health signals that may include improved insulin sensitivity and favorable shifts in energy expenditure in certain models.
Organ pathway interest including liver related signals in fatty liver models and kidney protection signals in select disease contexts.
Body fat reduction signals in obesity model contexts, typically framed as a downstream effect of increased oxidative capacity and metabolic efficiency.
Dosing
Strength | Dosage |
|---|---|
Low | 250-500mcg daily |
Average | 750-1000mcg daily |
High | 2mg+ daily |
Dosing is commonly split into 250-500mcg capsules x3-4 times a day
Safety Profile
SLU-PP-332 is frequently described in review discussions as having no significant side effects reported but that should be interpreted narrowly. Lack of reported adverse events in limited model settings does not establish long term safety in humans.
Because ERR signaling touches multiple metabolically active organs, tolerability should be treated as dose dependent and context dependent, and conservative interpretation is warranted.
Stacking
Fat Loss Stack
SLU-PP-332
BAM-15
Retatrutide
L-Carnitine
Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.
